AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism
Feinstein Institute for Medical Research · IJ Research (United States) · +4 more institutions
Abstract
Alzheimer disease is an age-related neurodegenerative disorder characterized by amyloid-beta (Abeta) peptide deposition into cerebral amyloid plaques. The natural polyphenol resveratrol promotes anti-aging pathways via the activation of several metabolic sensors, including the AMP-activated protein kinase (AMPK). Resveratrol also lowers Abeta levels in cell lines; however, the underlying mechanism responsible for this effect is largely unknown. Moreover, the bioavailability of resveratrol in the brain remains uncertain. Here we show that AMPK signaling controls Abeta metabolism and mediates the anti-amyloidogenic effect of resveratrol in non-neuronal and neuronal cells, including in mouse primary neurons.…
Citation impact
- FWCI
- 19.33
- Percentile
- 100%
- References
- 75
Authors
11- VVValérie Vingtdeux
Feinstein Institute for Medical Research
- LGLuca Giliberto
Feinstein Institute for Medical Research, IJ Research (United States)
- HZHaitian Zhao
IJ Research (United States), Feinstein Institute for Medical Research
- PCPallavi Chandakkar
Feinstein Institute for Medical Research, IJ Research (United States)
- QWQingli Wu
Rutgers, The State University of New Jersey, Purdue University West Lafayette, Department of Plant Biology
Topics & keywords
- Resveratrol
- AMPK
- Protein kinase A
- AMP-activated protein kinase
- Chemistry
- Neuroprotection
- Cell biology
- Kinase
- Good health and well-being